A. Stephen K. Hashmi et al.
FULL PAPERS
1310, 1219, 1188, 1161, 1124, 1021, 963, 909, 889, 849, 707,
631 cmÀ1.
24.2 mg, 3:7 mixture, thus the spectroscopic data of 11h
could be obtained when substracting the signals of pure
10h) was obtaimed.
4-[2-(5-Phenylfuran-2-yl)propyl]hepta-1,6-diyn-4-ol (10e):
Prepared according to the general procedure E using 10e
(561 mg, 1.96 mmol) and propargylmagnesium bromide
(5.40 mL, 5.88 mmol). After removal of the solvent under
vacuum and purification by column chromatography 10e
was obtained; yield: 352 mg (61%). Rf (petrol ether:ethyl
10h: Rf (petrol ether:ethyl acetate, 7:1)=0.23; IR (film):
˜
n=3292, 2921, 2858, 1615, 1569, 1430, 1383, 1270, 1217,
1074, 1020, 995, 983, 947, 862, 781, 632 cmÀ1 1H NMR
;
(CDCl3, 300 MHz): d=2.05 (m, 2H), 2.09 (t, J=2.6 Hz,
2H), 2.25 (d, J=1.2 Hz, 3H), 2.55 (dd, J=16.6 Hz, 2.6 Hz,
4H), 2.73 (m, 2H), 5.84 (dq, J=3.1 Hz, 1.2 Hz, 1H), 5.88 (d,
J=3.1 Hz, 1H); 13C NMR (CDCl3, 125 MHz): d=13.5 (q),
22.2 (t), 29.6 (t, 2C), 36.4 (t), 71.6 (s), 71.8 (d, 2C), 80.0 (s,
2C), 105.5 (d), 105.9 (d), 150.5 (s), 153.7 (s); MS (EI+,
70 eV): m/z (%)=216 (7) [M+], 177 (18), 159 (15), 135 (4),
96 (8), 95 (100), 77 (4), 43 (27), 32 (13), 28 (54), 18 (9); HR-
MS (EI+, 70 eV): m/z=216.1151, calcd. for C14H16O2:
216.1144.
˜
acetate, 5:1)=0.25; IR (film): n=3302, 3053, 2974, 1546,
1265, 1021, 790, 738, 704, 651 cmÀ1 1H NMR (CDCl3,
;
300 MHz): d =1.35 (d, J=6.9 Hz, 3H), 1.94 (dd, J=15.2 Hz,
4.74 Hz, 1H), 2.06 (t, 2H), 2.26 (dd, J=15.2 Hz, 4.7 Hz,
1H), 2. 50 (m, 4H), 3.16 (m, J=7.0 Hz, 1H), 6.11 (s, 1H),
6.5 (s, 1H), 7.20 (t, J=7. 7 Hz, 1H), 7.33 (t, J=7.7 Hz, 2H),
7.60 (d, J=7.7 Hz, 2H); 13C NMR (CDCl3, 125 MHz): d=
21.9 (q), 29.0 (d), 29.5 (t), 29.7 (t), 43.4 (t), 71.4 (d), 71.5 (d),
72.9 (s), 96.8 (s), 97.3 (s), 105.7 (d), 106.3 (d), 123.3 (d),
123.4 (d), 126.9 (d), 126.9 (d), 128. 6 (d, 2C), 131. 0 (s),
152.3 (s), 159.5 (s); HR-MS (FAB+): m/z=292.1467, calcd.
for [M+]=C20H20O2: 292.1463.
4-(2-(5-Phenylfuran-2-yl)ethyl)hepta-1,6-diyn-4-ol (10f):
Prepared according to the general procedure E using 9f
(870 mg, 3.78 mmol) and propargylmagnesium bromide
(5.80 mL, 11.3 mmol). After removal of the solvent under
vacuum and purification by column chromatography 10f
was obtained; yield: 701 mg (66%). Rf (petrol ether:ethyl
11h: Rf (petrol ether:ethyl acetate, 7:1)=0.23; 1H NMR
(CDCl3, 300 MHz): d=2.05 (m, 2H), 2.09 (t, 1H), 2.24 (s,
3H), 2.52 (dd, 2H), 2.73 (m, 2H), 4.98 (d, J=6.7 Hz, 2H),
5.36 (t, J=6.7 Hz, 1H), 5.83 (dq, J=3.1 Hz, 1H), 5.86 (d,
J=3.1 Hz, 1H); 13C NMR (CDCl3, 125 MHz): d=13.5 (q),
22.7 (t), 32.0 (t), 38.3 (t), 72.5 (d), 80.01 (s), 96.71 (s), 105.9
(d), 105.4 (d), 150.4 (s), 153.8 (s), 206.03 (s); C14H16O2 (216.
28).
2-Methyl-5-propyl-7-prop-2-yn-1-yl-5,6,7,8-tetrahydro-
naphthalene-1,7-diol (13a): Prepared according to the gener-
al procedure F using 10a (50.0 mg, 119 mmol) in acetonitrile-
d3 and AuCl3 (2.93 mg, 9.39 mmol, 5 mol%). After removal
of the solvent under vacuum 13a was obtained as an orange
oil; yield: 23.0 mg (46%). Rf (pentane:ethyl acetate=
˜
acetate, 5:1)=0.16; IR (film): n=3543, 3292, 2920, 2120,
1967, 1594, 1486, 1447, 1285, 1075, 1019, 964, 891, 760 cmÀ1
;
1H NMR (CDCl3, 300 MHz): d=2.05 (m, 2H), 2.09 (m,
2H), 2.53 (m, 4H), 2.78 (m, 2H), 6.04 (d, 1H, J=3.1 Hz),
6.47 (d, 1H, J=3.1 Hz), 7.15 (m, 1H), 7.29 (m, 2H), 7.57
(m, 2H); 13C NMR (CDCl3, 125 MHz): d=22.4 (t), 35.9 (t,
2C), 36.22 (t), 71.9 (d, 2C), 72.5 (s), 79.78 (s, 2C), 105.89 (d),
107.14 (d), 123.40 (d, 2C), 126.7 (d), 128.62 (d, 2C), 131.08
(s), 152.48 (s), 154.43 (s); anal. calcd. for C19H18O2 (278.13):
C 81.99, H 6.52; found: C 80.53 , H 6.52; HR-MS (ESI+):
m/z=301.1199, calcd. for [M+]=C19H18NaO2: 301.1204.
4-[2-(5-Methylfuran-2-yl)propyl]hepta-1,6-diyn-4-ol (10g):
Prepared according to the general procedure E using 9g
(554 mg, 2.47 mmol) and propargylmagnesium bromide
(3.61 mL, 7.40 mmol). After removal of the solvent under
vacuum and purification by column chromatography 10g
(yield:158 mg, 31%) and 11g (yield:17 mg) were obtained.
10g: Rf (petrol ether:ethyl acetate, 7:1)=0.25; IR (film):
˜
10:3)=0.25; IR (film): n=3412, 3271, 2955, 2932, 2870,
1
1631, 1493, 1464, 1303, 1226, 1037, 803, 647 cmÀ1; H NMR
(CDCl3, 300 MHz): d=0.93 (t, J=7.3 Hz, 3H), 1.22–1.45
(m, 2H), 1.49–1.62 (m, 2H), 1.68 (s, 1H), 1.84–2.11 (m, 2H),
1.92–1.95 (m, 1H), 2.12 (t, J=2.6 Hz, 2H), 2.18 (s, 3H), 2.54
(t, J=2.5 Hz,1H), 2.80 (dd, J=16.9 Hz, 1H), 3.05 (s, 1H),
6.86 (d, J=8.0 Hz, 1H), 6.95 (d, J=8.0 Hz, 1H); 13C NMR
(CDCl3, 125 MHz): d=14.4 (q), 15.5 (q), 19.4 (t), 33.6 (d),
33.7 (t) 35.1 (t), 37.7 (t), 38.6 (t), 69.7 (d), 71.7 (s), 80.4 (s),
118.1 (d), 119.6 (s), 120.3 (s), 128.1 (d), 138.6 (s), 151.75 (s);
HR-MS (ESI+): m/z=281.1512, calcd. for [M+Na+]=
C17H22ONa: 281.1514.
5-Isopropyl-2-methyl-7-(propyl-2-ynyl)-5,6,7,8-tetrahydro-
naphthalene-1,7-diol (13b): Prepared according to the gener-
al procedure F using 10b (30.0 mg, 120 mmol) in acetonitrile-
d3 and AuCl3 (1.8 mg, 12 mmol, 5 mol%). After removal of
the solvent under vacuum 13b was obtained as a brown oil;
yield: 27 mg (87%). Rf (petrol ether:ethyl acetate=10:1)=
˜
n=3293, 2965, 2921, 2858, 1957, 1710, 1614, 1566, 1435,
1362, 1280, 1219, 1069, 1019, 940, 852, 781, 633 cmÀ1
;
1H NMR (CDCl3, 300 MHz): d=1.32 (d, J=7.2 Hz, 3H),
1.94 (dd, J=14.7 Hz, 4.5 Hz, 1H), 2.09 (t, J=2.4 Hz, 2H),
2.18 (dd, J=14.7 Hz, 4.5 Hz, 1H), 2.25 (s, 3H), 2.55 (dd, J=
15.7 Hz, 2.4 Hz, 4H), 3.0 (m, J=7.2 Hz, 4.5 Hz, 1H), 5.84
(dq, J=3.1 Hz, 1.2 Hz, 1H), 5.88 (d, J=3.1 Hz, 1H);
13C NMR (CDCl3, 125 MHz): d=13.5 (q), 21.9 (q), 28.9 (t),
29.6 (t), 29.9(t), 71.4 (d, 2C), 73.0 (s), 80.2 (d, 2C), 104.9 (d),
105.9 (d), 150.5 (s), 157.7 (s); MS (EI+, 70 eV): m/z (%)=
230 (18) [M+], 191 (29), 173 (24), 109 (100), 43 (21), 39 (9);
anal. calcd. for C15H18O2 (230.30): C 78.23, H 7.88; found: C
77.76, H 8.00.
˜
0.05; IR (film): n=3416, 3303, 2958, 2928, 2871, 1462, 1422,
1308, 1227, 1194, 1091, 1057, 954 cmÀ1 1H NMR (CDCl3,
;
300 MHz): d=0.59 (d, J=6.7 Hz, 3H), 1.04 (d, J=6.7 Hz,
3H), 1.59 (m, 2H), 1.89 (m, 1H), 2.18 (s, 3H), 2.29 (t, J=
2.6 Hz, 1H), 2.47 (m, 1H), 2.50 (d, J=2.6 Hz, 2H), 2.90 (dd,
J=16.5 Hz, 2.80 Hz, 1H), 2.99 (dd, J=16.5 Hz, 2.8 Hz, 1H),
6.8 (d, J=7.7 Hz, 1H), 6.96 (d, J=7.7 Hz, 1H); 13C NMR
(CDCl3, 125 MHz): d=15.7 (q), 20.9 (q), 29.3 (t), 30.8 (q),
34.3 (d), 35.3 (d), 36.1 (t), 39.8 (t), 70.0 (d), 71.8 (s), 80.9 (s),
119.0 (d), 119.4 (s), 121.5 (d), 128.4 (s), 138.5 (s), 152.2 (s);
MS (FAB+, 70 eV): m/z (%)=258 (24) [M+], 241 (31), 217
(27), 201 (19), 176 (23), 154 (100), 137, 136 (100), 107 865);
HR-MS (FAB+): m/z=258.1606, calcd. for [M+]=C17H27O2:
258.1620.
4-[2-(5-Methylfuran-2-yl)ethyl]hepta-1,6-diyn-4-ol (10h):
Prepared according to the general procedure E using 9h
(400 mg, 1.90 mmol) and Grignard reagent (7.00 mL,
7.60 mmol). After removal of the solvent in vacuum 10h
(yield: 182 mg, 44%) and a mixture of 10h and 11h (yield:
2478
ꢁ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2009, 351, 2469 – 2481